Literature DB >> 29934633

Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection.

Suman Pilli1, Peck Lin Lip2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29934633      PMCID： PMC6224612          DOI： 10.1038/s41433-018-0156-6

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Presumed entecavir-induced ocular toxicity.

Authors:  M K M Muqit; P E Stanga; F J Vilar; N Patton
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

Review 2.  Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B.

Authors:  G L-H Wong; W-K Seto; V W-S Wong; M-F Yuen; H L-Y Chan
Journal:  Aliment Pharmacol Ther       Date:  2018-01-22       Impact factor: 8.171

Review 3.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.